在HFpEF患者没有交感静脉缩剂储备的情况下,运动血液动力学反应受损
Claire E Kissell1, Rachel J Skow2, Denis J Wakeham3
1Department of Kinesiology, University of Texas at Arlington, Arlington, TX, United States of America.
Autonomic neuroscience : basic & clinical
|June 25, 2025
概括
患有心力衰竭的患者保留喷射分数 (HFpEF),在冷压力测试期间无法收缩血管,在运动期间显示腿部血流减少. 这表明HFpEF患者缺乏交感血管缩剂储备的血液动力学反应受损.
科学领域:
- 心血管生理学心血管生理学
- 运动科学 运动科学
- 心脏衰竭研究研究
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭与运动高血压受损和静脉缩器反应迟有关.
- 在HFpEF患者中,血管扩张能力和交感血管收缩剂储备的减少存在显著的异质性.
研究的目的:
- 为了调查HFpEF患者在冷压力测试 (CPT) 期间无法进行血管收缩,在单腿膝盖伸缩器 (SLKE) 运动中表现出脚血流 (LBF) 反应,与那些可以进行血管收缩的人相比.
- 在HFpEF中检查交感血管收缩储备和运动血液动力学之间的关系.
主要方法:
- 43名HFpEF患者接受了CPT,以评估血管收缩反应,将其分类为收缩或非收缩.
- 参与者进行了下最大和峰值SLKE运动,并持续监测心率,血压和常见的股骨动脉血流.
- 计算了CPT和运动期间腿部血管导电率 (LVC) 的变化.
主要成果:
- 与约束者相比,非约束者在亚最大SLKE运动期间LBF和LVC的增加较小 (分别P=0.011和P=0.007).
- 峰值运动LBF在非收缩者中也明显低于收缩者 (P=0.033).
- 非收缩者在CPT期间显示了+26%的Δ LVC,而收缩者显示了-15%的Δ LVC.
结论:
- 缺乏交感血管收缩剂储备 (非收缩剂) 的HFpEF患者在运动期间表现出受损的血液动力学反应.
- 在HFpEF中,在运动期间适当调节血液流动时,响应同情激发的血管收缩能力至关重要.
- 这些发现强调了评估血管收缩剂储备的重要性,以了解HFpEF的运动不耐受性.
相关概念视频
01:29Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
01:17Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
01:20Exercise and Cardiovascular Response
1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
01:22Heart Failure Drugs: β-Blockers
445
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
445
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39